Search - tctmd.com

Displaying 1 - 20 of 99

Sort: Relevancy | Date

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

ECLIPSE: Balloon Angioplasty as Good as Orbital Atherectomy in Calcified Lesions

News Conference News TCT 2024

ECLIPSE: Orbital Atherectomy No Better Than Balloon Angioplasty in Calcified Lesions

Yael L. Maxwell

October 29, 2024

Presentation TCT 2024

How Can Clinical Trials Mobilize the Diversity Efforts?

Presenter: Roxana Mehran

October 29, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

Todd Neale

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

Presentation TCT 2022

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Presenter: C. Michael Gibson

September 18, 2022

Presentation TCT 2022

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Presenter: Clyde Yancy

September 18, 2022

Advertisement

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

ECLIPSE: Orbital Atherectomy No Better Than Balloon Angioplasty in Calcified Lesions

How Can Clinical Trials Mobilize the Diversity Efforts?

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

LAAO Outcomes Similar Regardless of Operator’s Specialty

What’s Going to Be Big at TCT 2024?

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content